Home/Filings/4/0001127602-24-026897
4//SEC Filing

Rathbun Joel R. 4

Accession 0001127602-24-026897

CIK 0001122976other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 9:33 AM ET

Size

16.5 KB

Accession

0001127602-24-026897

Insider Transaction Report

Form 4
Period: 2024-11-07
Rathbun Joel R.
SVP, Mergers & Acquisitions
Transactions
  • Disposition to Issuer

    Common Stock

    2024-11-07$51.44/sh8,036$413,3722,064 total
  • Exercise/Conversion

    Common Stock

    2024-11-07$34.10/sh+10,100$344,41010,100 total
  • Exercise/Conversion

    Common Stock

    2024-11-07$31.54/sh+17,150$540,91119,214 total
  • Disposition to Issuer

    Common Stock

    2024-11-07$51.45/sh13,452$692,1325,762 total
  • Sale

    Common Stock

    2024-11-07$51.45/sh5,762$296,4320 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-11-0710,1000 total
    Exercise: $34.10Exp: 2027-02-15Common Stock (10,100 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    2024-11-0717,15017,150 total
    Exercise: $31.54Exp: 2029-02-11Common Stock (17,150 underlying)
Holdings
  • Common Stock

    (indirect: Supplemental Plan)
    28,566.359
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.44 to $51.452, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
  • [F2]The information in this report is based on a plan statement as of November 7, 2024.
  • [F3]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years.
  • [F4]SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

Issuer

AVIENT CORP

CIK 0001122976

Entity typeother

Related Parties

1
  • filerCIK 0001661555

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 9:33 AM ET
Size
16.5 KB